p53 and MDM2 expression in odontogenic cysts and tumours

被引：0
|
作者：
Carvalhais, JN
de Aguiar, MCF
de Araújo, VC
de Araújo, NS
Gomez, RS
机构：
[1] Univ Fed Minas Gerais, Sch Dent, Dept Oral Surg & Pathol, BR-30380030 Belo Horizonte, MG, Brazil
[2] Univ Sao Paulo, Sch Dent, Dept Oral Pathol, Sao Paulo, Brazil
来源：
ORAL DISEASES | 1999年 / 5卷 / 03期
关键词：
p53; MDM2; odontogenic cysts; odontogenic tumours; immunohistochemistry;
D O I：
暂无
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
OBJECTIVE: The aim of this report was to assess p53 and MDM2 expression in odontogenic cysts and tumours, as they are known to play important roles in cell proliferation and tumorigenesis. MATERIALS AND METHODS: The expression of p53 and MDM2 proteins was determined immunohistochemically in 51 formalin-fixed, paraffin embedded specimens of odontogenic cysts and tumours. RESULTS: No positivity to p53 was found in the cases studied. MDM2 expression in ameloblastoma was higher than in radicular cysts, but lower than that observed in odontogenic keratocysts. No difference was observed between MDM2 expression in radicular cyst and adenomatoid odontogenic tumour. The clear-cell odontogenic ametoblastoma presented strong immunoreaction to this antigen. CONCLUSIONS: The results suggest that MDM2 overexpression may be involved in the pathogenesis of some odontogenic lesions.
引用
收藏
页码：218 / 222
页数：5
相关论文
共 50 条
  • [31] RYBP stabilizes p53 by modulating MDM2
    Chen, Deng
    Zhang, Jianbing
    Li, Mao
    Rayburn, Elizabeth R.
    Wang, Hui
    Zhang, Ruiwen
    EMBO REPORTS, 2009, 10 (02) : 166 - 172
  • [32] Mdm2: Keeping p53 under control
    Piette, J
    Neel, H
    Marechal, V
    ONCOGENE, 1997, 15 (09) : 1001 - 1010
  • [33] p53 and Mdm2: not all cells are equal
    Coates, P. J.
    JOURNAL OF PATHOLOGY, 2007, 213 (04) : 357 - 359
  • [34] The Mdm2 and p53 genes are conserved in the Arachnids
    Lane, David P.
    Cheok, Chit Fang
    Brown, Christopher J.
    Madhumalar, Arumugam
    Ghadessy, Farid J.
    Verma, Chandra
    CELL CYCLE, 2010, 9 (04) : 748 - 754
  • [35] Transcription factors that interact with p53 and Mdm2
    Inoue, Kazushi
    Fry, Elizabeth A.
    Frazier, Donna P.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (07) : 1577 - 1585
  • [36] Inhibition of p53 degradation by Mdm2 acetylation
    Wang, XJ
    Taplick, J
    Geva, N
    Oren, M
    FEBS LETTERS, 2004, 561 (1-3): : 195 - 201
  • [37] p53 gene status and expression of p53, MDM2, and p14ARF proteins in ameloblastomas
    Kumamoto, H
    Izutsu, T
    Ohki, K
    Takahashi, N
    Ooya, K
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2004, 33 (05) : 292 - 299
  • [38] MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma
    Ambros, RA
    Sheehan, CE
    Kallakury, BVS
    Ross, JS
    Malfetano, J
    Paunovich, E
    Figge, J
    MODERN PATHOLOGY, 1996, 9 (12) : 1165 - 1169
  • [39] Expression of p53 and mdm2 and their significance in recurrence of superficial bladder cancer
    Tuna, B
    Yörükoglu, K
    Tüzel, E
    Güray, M
    Mungan, U
    Kirkali, Z
    PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (05) : 323 - 328
  • [40] Activation of p53 by roscovitine-mediated suppression of MDM2 expression
    Lu, WG
    Chen, LH
    Peng, YH
    Chen, JD
    ONCOGENE, 2001, 20 (25) : 3206 - 3216
12345